3rd Therapeutics Discovery
Convention Center, KSAU-HS. 10-11-12 October 2023
2023-10-10 03:00:00
Registration
Abstract Submission
  • ABSTRACT SUBMISSION
  • Home
  • About
    • OBJECTIVES
    • EXECUTIVE DIRECTOR MESSAGE
    • CONFERENCE CHAIRMAN MESSAGE
    • CONTACT US
  • SPEAKERS
    • SPEAKER LIST
    • MEET THE EXPERTS
  • PROGRAM
    • CONFERENCE PROGRAM
    • PRE-CONFERENCE WORKHOPS
  • EVENT DETAILS
    • REGISTERATION
      • ATTEND THE CONFERENCE
    • ABSTRACT SUBMISSION
      • ABSTRACT SUBMISSION
    • CONFERENCE DETAILS
      • ORGANIZERS
    • POSTERS
      • EVENT POSTER
      • POSTER TEMPLATE
      • POSTER GUIDELINES
      • POSTER REVIEW PANEL
    • CME
      • CME
  • Home
  • About
    • OBJECTIVES
    • EXECUTIVE DIRECTOR MESSAGE
    • CONFERENCE CHAIRMAN MESSAGE
    • CONTACT US
  • SPEAKERS
    • SPEAKER LIST
    • MEET THE EXPERTS
  • PROGRAM
    • CONFERENCE PROGRAM
    • PRE-CONFERENCE WORKHOPS
  • EVENT DETAILS
    • REGISTERATION
      • ATTEND THE CONFERENCE
    • ABSTRACT SUBMISSION
      • ABSTRACT SUBMISSION
    • CONFERENCE DETAILS
      • ORGANIZERS
    • POSTERS
      • EVENT POSTER
      • POSTER TEMPLATE
      • POSTER GUIDELINES
      • POSTER REVIEW PANEL
    • CME
      • CME
Dr-Said-Dermime

Dr. Said Dermime

Director of Translational Cancer Research Facility, Hamad Medical City, Doha, Qatar

Dr Said Dermime graduated with BSc. Degree in Biological Sciences from the University of Constantine, Algeria in 1985. He then received his MSc and PhD degrees in immunology from Salford University, Manchester, UK in 1987 and 1992 respectively. After that, he joined the National Cancer Institute, Milan, Italy for a period of 2 years as postdoctoral fellow and the NHLBI, NIH, Bethesda, USA, for another 2 years fellowship under an NIH Fogarty International Award. To gain industrial experience, he worked at PPL Therapeutics Limited, London, UK, and COBRA Therapeutics Ltd., UK for a period of 2 years. Dr Dermime was appointed in 1998 at the Paterson Institute for Cancer Research, Manchester, UK, as a lymphoma-cancer-vaccine Team Leader for 4 years. Subsequently, he established and led the Tumor Immunology Section at King Faisal Specialist Hospital & Research Centre, Riyadh, KSA, for a period of 6 years as a senior scientist. Dr Dermime joined after that the Dasman Diabetes Institute in Kuwait in 2008 to establish and lead the department of Biomedical Research and to head the Immunology & Innovative Cell Therapy Unit. In December 2012, he joined King Fahad Specialist Hospital in Dammam, Saudi Arabia to establish the Biomedical Research Facility and to head the Immunology & Innovative Cell therapy Program. Recently, he was recruited by the National Centre for Cancer Care and Research (NCCCR), Hamad Medical Corporation to establish and Lead the Translational Cancer Research Facility.

Therapeutics Discovery. 10-11-12 October 2023
Contact us

Contacts
KSAU-HS, Al Hars Al Watani, Ar Rimayah Riyadh 14611 Saudi Arabia
KAIMRC-Therapeutics@ngha.med.sa
LINKS
  • Therapeutics Discovery Conference
  • Objectives
  • About Therapeutics Discovery Conference
© 2021 KAIMRC - Advance Computing & Technologies, All Rights Reserved.